{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T10:57:27Z","timestamp":1743159447646},"reference-count":48,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2000,7,1]],"date-time":"2000-07-01T00:00:00Z","timestamp":962409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2000,7]]},"DOI":"10.1006\/mgme.2000.3003","type":"journal-article","created":{"date-parts":[[2002,9,18]],"date-time":"2002-09-18T15:46:30Z","timestamp":1032363990000},"page":"163-169","source":"Crossref","is-referenced-by-count":16,"title":["Approach to Gene Therapy of Glycogenosis Type II (Pompe Disease)"],"prefix":"10.1006","volume":"70","author":[{"given":"Livia","family":"Poenaru","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1006\/mgme.2000.3003_RF1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1042\/bj0860011","article-title":"Alpha-glucosidase deficiency in generalized glycogen storage disease (Pompe disease)","volume":"86","author":"Hers","year":"1963","journal-title":"Biochem J"},{"key":"10.1006\/mgme.2000.3003_RF2","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/(SICI)1096-8628(19980827)79:1<69::AID-AJMG16>3.0.CO;2-K","article-title":"Carrier frequency for glycogen storage disease type II in New York and estimates of affected individuals born with the disease","volume":"79","author":"Martiniuk","year":"1998","journal-title":"Am J Med Genet"},{"key":"10.1006\/mgme.2000.3003_RF3","series-title":"The Metabolic and Molecular Bases of Inherited Disease","first-page":"2443","article-title":"Glycogen storage disease type II: Acid \u03b1-glucosidase (acid maltase) deficiency","author":"Hirschhorn","year":"1995"},{"key":"10.1006\/mgme.2000.3003_RF4","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/00005792-199505000-00002","article-title":"Clinical variability in adult-onset acid maltase deficiency: Report of affected sibs and review of the literature","volume":"74","author":"Felice","year":"1995","journal-title":"Medicine"},{"key":"10.1006\/mgme.2000.3003_RF5","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1212\/WNL.23.1.95","article-title":"The spectrum and diagnosis of acid maltase deficiency","volume":"23","author":"Engel","year":"1973","journal-title":"Neurology"},{"key":"10.1006\/mgme.2000.3003_RF6","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/S0887-8994(99)00064-8","article-title":"Hydrocephalus associated with glycogen storage disease type II (Pompe disease)","volume":"21","author":"Sahin","year":"1999","journal-title":"Pediatr Neurol"},{"key":"10.1006\/mgme.2000.3003_RF7","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1055\/s-2007-1024453","article-title":"Differential diagnosis in anorexia nervosa: Glycogenosis II (the Pompe type)","volume":"124","author":"Fischer","year":"1999","journal-title":"Dtsch Med Wochenschr"},{"key":"10.1006\/mgme.2000.3003_RF8","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/(SICI)1096-8628(19971017)72:2<135::AID-AJMG3>3.0.CO;2-U","article-title":"Nosology of lysosomal glycogen storage diseases without in vitro acid maltase deficiency: Delineation of a neonatal form","volume":"72","author":"Verloes","year":"1997","journal-title":"Am J Med Genet"},{"key":"10.1006\/mgme.2000.3003_RF9","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/00005072-197107000-00008","article-title":"Nervous system in Pompe disease: Ultrastructure and biochemistry","volume":"30","author":"Gambetti","year":"1971","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1006\/mgme.2000.3003_RF10","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/BF00313272","article-title":"Acid maltase deficiency in nonidentical adult twins: A morphological and biochemical study","volume":"213","author":"Martin","year":"1976","journal-title":"J Neurol"},{"key":"10.1006\/mgme.2000.3003_RF11","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1089\/dna.1991.10.283","article-title":"Isolation and partial characterization of the structural gene for human acid alpha-glucosidase","volume":"10","author":"Martiniuk","year":"1991","journal-title":"DNA Cell Biol"},{"key":"10.1006\/mgme.2000.3003_RF12","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/oxfordjournals.jbchem.a122457","article-title":"Intracellular transport of acid alpha-glucosidase in human fibroblasts: Evidence for involvement of phosphomannosyl receptor-independent system","volume":"104","author":"Tsuji","year":"1998","journal-title":"J Biochem (Tokyo)"},{"key":"10.1006\/mgme.2000.3003_RF13","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1002\/mus.880181415","article-title":"Genetic defects in patients with glycogenosis type II (acid maltase deficiency)","volume":"3","author":"Raben","year":"1995","journal-title":"Muscle Nerve"},{"key":"10.1006\/mgme.2000.3003_RF14","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1002\/mus.880181414","article-title":"Glycogenosis type II (acid maltase deficiency)","volume":"3","author":"Reuser","year":"1995","journal-title":"Muscle Nerve"},{"key":"10.1006\/mgme.2000.3003_RF15","doi-asserted-by":"crossref","first-page":"19086","DOI":"10.1074\/jbc.273.30.19086","article-title":"Targeted disruption of the acid alpha-glucosidase gene in mice causes an illness with critical features of both infantile and adult human glycogen storage disease type II","volume":"273","author":"Raben","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1006\/mgme.2000.3003_RF16","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/hmg\/7.1.53","article-title":"Generalized glycogen storage and cardiomegaly in a knockout mouse model of Pompe disease","volume":"7","author":"Bijvoet","year":"1998","journal-title":"Hum Mol Genet"},{"key":"10.1006\/mgme.2000.3003_RF17","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/(SICI)1096-9896(199911)189:3<416::AID-PATH445>3.0.CO;2-6","article-title":"Pathological features of glycogen storage disease type II highlighted in the knockout mouse model","volume":"189","author":"Bijvoet","year":"1999","journal-title":"J Pathol"},{"key":"10.1006\/mgme.2000.3003_RF18","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1212\/WNL.33.1.34","article-title":"Improvement of muscle function in acid maltase deficiency by high-protein therapy","volume":"33","author":"Slonim","year":"1983","journal-title":"Neurology"},{"key":"10.1006\/mgme.2000.3003_RF19","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s004210050180","article-title":"Effects of 3 days of carbohydrate supplementation on muscle glycogen content and utilisation during a 1-h cycling performance","volume":"75","author":"Hawley","year":"1997","journal-title":"Eur J Appl Physiol"},{"key":"10.1006\/mgme.2000.3003_RF20","first-page":"386","article-title":"Bone marrow transplantation for glycogen storage disease type II (Pompe disease)","volume":"314","author":"Watson","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1006\/mgme.2000.3003_RF21","first-page":"184","article-title":"Enzyme replacement in Pompe disease: An attempt with purified human acid alpha-glucosidase","volume":"9","author":"De Barsy","year":"1973","journal-title":"Birth Defects"},{"key":"10.1006\/mgme.2000.3003_RF22","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1172\/JCI115025","article-title":"Intravenous administration of phosphorylated acid alpha-glucosidase leads to uptake of enzyme in heart and skeletal muscle of mice","volume":"87","author":"Van der Ploeg","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1006\/mgme.2000.3003_RF23","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1203\/00006450-199803000-00011","article-title":"Recombinant human acid alpha-glucosidase corrects acid alpha-glucosidase-deficient human fibroblasts, quail fibroblasts, and quail myoblasts","volume":"43","author":"Yang","year":"1998","journal-title":"Pediatr Res"},{"key":"10.1006\/mgme.2000.3003_RF24","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1073\/pnas.93.1.65","article-title":"High-level production of recombinant human lysosomal acid alpha-glucosidase in Chinese hamster ovary cells which targets to heart muscle and corrects glycogen accumulation in fibroblasts from patients with Pompe disease","volume":"93","author":"Van Hove","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1006\/mgme.2000.3003_RF25","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1172\/JCI1722","article-title":"Clinical and metabolic correction of Pompe disease by enzyme therapy in acid maltase-deficient quail","volume":"101","author":"Kikuchi","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1006\/mgme.2000.3003_RF26","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1093\/hmg\/7.11.1815","article-title":"Recombinant human acid alpha-glucosidase: High level production in mouse milk, biochemical characteristics, correction of enzyme deficiency in GSDII KO mice","volume":"7","author":"Bijvoet","year":"1998","journal-title":"Hum Mol Genet"},{"key":"10.1006\/mgme.2000.3003_RF27","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1093\/hmg\/8.12.2145","article-title":"Human acid alpha-glucosidase from rabbit milk has therapeutic effect in mice with glycogen storage disease type II","volume":"8","author":"Bijvoet","year":"1999","journal-title":"Hum Mol Genet"},{"key":"10.1006\/mgme.2000.3003_RF28","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/oxfordjournals.bmb.a072942","article-title":"Myoblast-based gene therapies","volume":"51","author":"Partridge","year":"1995","journal-title":"Brit Med Bull"},{"key":"10.1006\/mgme.2000.3003_RF29","doi-asserted-by":"crossref","first-page":"10892","DOI":"10.1073\/pnas.89.22.10892","article-title":"Gene therapy via primary myoblasts: Long term expression of factor IX protein following transplantation in vivo","volume":"89","author":"Dai","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1006\/mgme.2000.3003_RF30","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1089\/10430349950019219","article-title":"Neonatal intramuscular injection with recombinant adeno-associated virus results in prolonged \u03b2-glucuronidase expression in situ and correction of liver, pathology in mucopolysaccharidosis type VII mice","volume":"10","author":"Daly","year":"1999","journal-title":"Hum Gene Ther"},{"key":"10.1006\/mgme.2000.3003_RF31","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1093\/hmg\/8.5.831","article-title":"Adenoviral gene therapy of the Tay-Sachs disease in hexosaminidase A-deficient knock-out mice","volume":"8","author":"Guidotti","year":"1999","journal-title":"Hum Mol Genet"},{"key":"10.1006\/mgme.2000.3003_RF32","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1128\/JVI.73.3.1949-1955.1999","article-title":"Structure of adeno-associated virus vector DNA following transduction of the skeletal muscle","volume":"73","author":"Vincent-Lacaze","year":"1999","journal-title":"J Virol"},{"key":"10.1006\/mgme.2000.3003_RF33","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1089\/10430349950018193","article-title":"Insulin production by engineered muscle cells","volume":"10","author":"Gros","year":"1999","journal-title":"Hum Gene Ther"},{"key":"10.1006\/mgme.2000.3003_RF34","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nm0497-429","article-title":"Gene therapy of murine motor neuron disease using adenoviral vectors for neurotrophic factors","volume":"3","author":"Haase","year":"1997","journal-title":"Nature Med"},{"key":"10.1006\/mgme.2000.3003_RF35","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1089\/hum.1995.6.10-1265","article-title":"Transient expression of genes transferred in vivo into heart using first-generation adenoviral vectors: Role of the immune response","volume":"6","author":"Gilgenkrantz","year":"1995","journal-title":"Hum Gene Ther"},{"key":"10.1006\/mgme.2000.3003_RF36","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/sj.gt.3300853","article-title":"Gene delivery to the myocardium by intrapericardial injection","volume":"6","author":"Fromes","year":"1999","journal-title":"Gene Ther"},{"key":"10.1006\/mgme.2000.3003_RF37","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/ng1093-130","article-title":"Long-term correction of mouse dystrophic degeneration by adenovirus-mediated transfer of a minidystrophin gene","volume":"5","author":"Vincent","year":"1993","journal-title":"Nature Genet"},{"key":"10.1006\/mgme.2000.3003_RF38","unstructured":"Bruder, J, T, Chen, P, Kovesdi, I, Effective repeat administration with adenovirus vectors to the muscle, ASGT Meeting (Washington), 1998, abstract 510."},{"key":"10.1006\/mgme.2000.3003_RF39","doi-asserted-by":"crossref","first-page":"4262","DOI":"10.1073\/pnas.96.8.4262","article-title":"High-efficiency gene transfer into skeletal muscle mediated by electric pulses","volume":"96","author":"Mir","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1006\/mgme.2000.3003_RF40","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/6981","article-title":"Synthetic muscle promoters: Activities exceeding naturally occurring regulatory sequences","volume":"17","author":"Li","year":"1999","journal-title":"Nat Biotechnol"},{"key":"10.1006\/mgme.2000.3003_RF41","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1089\/hum.1997.8.13-1555","article-title":"Retroviral transfer of acid \u03b1-glucosidase to enzyme deficient myoblasts results in phenotype spread of the genotypic correction by both secretion and fusion","volume":"8","author":"Zaretsky","year":"1997","journal-title":"Hum Gene Ther"},{"key":"10.1006\/mgme.2000.3003_RF42","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1093\/hmg\/7.11.1695","article-title":"Adenovirus-mediated transfer of the acid alpha-glucosidase gene into fibroblasts, myoblasts and myotubes from patients with glycogen storage disease type II leads to high level expression of enzyme and corrects glycogen accumulation","volume":"7","author":"Nicolino","year":"1998","journal-title":"Hum Mol Genet"},{"key":"10.1006\/mgme.2000.3003_RF43","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/sj.gt.3300609","article-title":"Complete correction of acid \u03b1-glucosidase deficiency in Pompe disease fibroblasts in vitro, and lysosomally targeted expression in neonatal rat cardiac and skeletal muscle","volume":"5","author":"Pauly","year":"1998","journal-title":"Gene Ther"},{"key":"10.1006\/mgme.2000.3003_RF44","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1089\/hum.1998.9.11-1609","article-title":"Adenovirus-mediated transfer of human acid maltase gene reduces glycogen accumulation in skeletal muscle of Japanese quail with acid maltase deficiency","volume":"9","author":"Tsujino","year":"1998","journal-title":"Hum Gene Ther"},{"key":"10.1006\/mgme.2000.3003_RF45","first-page":"A397","article-title":"A potential paradigm for the treatment of lysosomal disorders via modified adenovirus mediated gene therapy","volume":"64","author":"Amalfitano","year":"1998","journal-title":"Am J Hum Genet"},{"key":"10.1006\/mgme.2000.3003_RF46","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nm0596-545","article-title":"Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors","volume":"2","author":"Tripathy","year":"1996","journal-title":"Nature Genet"},{"key":"10.1006\/mgme.2000.3003_RF47","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1089\/hum.1997.8.10-1275","article-title":"Immune responses to reporter proteins and high viral dose limit duration of expression with adenoviral vectors: Comparison of E2a wild type and E2a deleted vectors","volume":"8","author":"Morral","year":"1997","journal-title":"Hum Gene Ther"},{"key":"10.1006\/mgme.2000.3003_RF48","doi-asserted-by":"crossref","unstructured":"Kochanek, S, Clemens, P, R, Mitani, K, Chen, H, H, Chan, S, Caskey, C, T. A new adenoviral vector: Replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and \u03b2-galactosidase. Proc Natl Acad Sci USA93:5731\u20135736, 1996.","DOI":"10.1073\/pnas.93.12.5731"}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719200930038?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719200930038?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,2]],"date-time":"2021-05-02T22:07:09Z","timestamp":1619993229000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719200930038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,7]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2000,7]]}},"alternative-id":["S1096719200930038"],"URL":"https:\/\/doi.org\/10.1006\/mgme.2000.3003","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2000,7]]}}}